These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Phae II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy. Denefrio JM, Vogel CL. Cancer Treat Rep; 1978 Jan; 62(1):173-5. PubMed ID: 414835 [No Abstract] [Full Text] [Related]
24. VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary. Samson MK, Baker LH, Talley RW, Fraile RJ. Eur J Cancer (1965); 1978 Dec; 14(12):1395-9. PubMed ID: 216556 [No Abstract] [Full Text] [Related]
29. Hexamethylmelamine in inoperable bronchogenic carcinoma. Takita H. N Y State J Med; 1972 Feb 15; 72(4):477-80. PubMed ID: 4334448 [No Abstract] [Full Text] [Related]
30. Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26. Gad-el-Mawla NM, Muggia FM, Hamza MR, El-Morsi B, Sherif M, Mansour MA, Khafagy M, El-Sebai IT. Cancer Treat Rep; 1978 Jul 15; 62(7):993-6. PubMed ID: 99234 [No Abstract] [Full Text] [Related]
31. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas. Mischler NE, Tormey DC, Klotz J, Borden EC, Ramirez G, Banerjee TK, Carr RM, Zaentz SD, Graf J. Cancer Clin Trials; 1981 Jul 15; 4(4):407-10. PubMed ID: 7318122 [Abstract] [Full Text] [Related]
33. Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamine. Connors TA, Cumber AJ, Ross WC, Clarke SA, Mitchley BC. Cancer Treat Rep; 1977 Aug 15; 61(5):927-8. PubMed ID: 408005 [No Abstract] [Full Text] [Related]
34. [Dibromodulcitol in combination with actinotherapy of spinocellular carcinoma]. Petruzelka L, Konopásek B, Betka J, Klozar J, Kvapil F, Mazánek J, Růzicka V, Prokes K. Sb Lek; 1984 Sep 15; 86(8-9):259-64. PubMed ID: 6505608 [No Abstract] [Full Text] [Related]
37. Phase II trial of cisplatin in small cell carcinoma of the lung. Levenson RM, Ihde DC, Huberman MS, Cohen MH, Bunn PA, Minna JD. Cancer Treat Rep; 1981 Sep 15; 65(9-10):905-7. PubMed ID: 6268297 [Abstract] [Full Text] [Related]
38. Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents. Bonomi PD, Mladineo J, Morrin B, Wilbanks G, Slayton RE. Cancer Treat Rep; 1979 Jan 15; 63(1):137-8. PubMed ID: 105805 [No Abstract] [Full Text] [Related]